C12N 2720/12343
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2720/12343 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for producing artificial recombinant RNA virus stably retaining foreign gene20 May 2025US 12,305,192 B2Osaka University
- Control of replication and transcription of self-replicating RNA in response to small molecules12 Nov 2024US 12,139,721 B2Massachusetts Institute of Technology
- Method for virus propagation19 Apr 2022US 11,306,293 B2Cytiva Sweden AB
- Genetically modified vero cells16 Apr 2026US 2026/0103682 A1Washington University
- Recombinant rotavirus expressing exogenous protein and uses thereof21 Aug 2025US 2025/0263443 A1The Trustees of Indiana University
- Rotavirus vectors for heterologous gene delivery20 Jun 2024US 2024/0200099 A1Merck Sharp & Dohme Corp.
- Method for preparing artificial recombinant rna virus that stably holds foreign gene10 Nov 2022US 2022/0356491 A1Osaka University
- Control of replication and transcription of self-replicating rna in response to small molecules21 Oct 2021US 2021/0324413 A1Massachusetts Institute of Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.